These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 6216999

  • 1. Regulation of the C3 nephritic factor stabilized C3/C5 convertase of complement by purified human erythrocyte C3b receptor.
    Daha MR, Kok DJ, Van Es LA.
    Clin Exp Immunol; 1982 Oct; 50(1):209-14. PubMed ID: 6216999
    [Abstract] [Full Text] [Related]

  • 2. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E, Kazatchkine MD, Mecarelli-Halbwachs L.
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [Abstract] [Full Text] [Related]

  • 3. A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosus.
    Waldo FB, Forristal J, Beischel L, West CD.
    J Clin Invest; 1985 Jun; 75(6):1786-95. PubMed ID: 3159752
    [Abstract] [Full Text] [Related]

  • 4. C3 nephritic factor protects bound C3bBb from cleavage by factor I and human erythrocytes.
    Mold C, Medof ME.
    Mol Immunol; 1985 May; 22(5):507-12. PubMed ID: 3848661
    [Abstract] [Full Text] [Related]

  • 5. Stabilization of the amplification convertase of complement by monoclonal antibodies directed against human factor B.
    Daha MR, Deelder AM, Van Es LA.
    J Immunol; 1984 May; 132(5):2538-42. PubMed ID: 6232321
    [Abstract] [Full Text] [Related]

  • 6. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Fearon DT.
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
    [Abstract] [Full Text] [Related]

  • 7. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK.
    J Immunol; 1986 Mar 15; 136(6):2216-21. PubMed ID: 2419425
    [Abstract] [Full Text] [Related]

  • 8. Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase.
    Daha MR, van Es LA.
    J Immunol; 1979 Mar 15; 122(3):801-5. PubMed ID: 448075
    [Abstract] [Full Text] [Related]

  • 9. Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria.
    Parker CJ, Baker PJ, Rosse WF.
    J Clin Invest; 1982 Feb 15; 69(2):337-46. PubMed ID: 6915939
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
    Gigli I, Sorvillo J, Mecarelli-Halbwachs L, Leibowitch J.
    J Exp Med; 1981 Jul 01; 154(1):1-12. PubMed ID: 7019379
    [Abstract] [Full Text] [Related]

  • 11. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
    Seya T, Holers VM, Atkinson JP.
    J Immunol; 1985 Oct 01; 135(4):2661-7. PubMed ID: 3161944
    [Abstract] [Full Text] [Related]

  • 12. Further evidence for the antibody nature of C3 nephritic factor (C3NeF).
    Daha MR, van Es LA.
    J Immunol; 1979 Aug 01; 123(2):755-8. PubMed ID: 379217
    [Abstract] [Full Text] [Related]

  • 13. Regulation of C5 convertase activity by properdin, factors B and H.
    Weiler JM.
    Immunol Res; 1989 Aug 01; 8(4):305-15. PubMed ID: 2531781
    [No Abstract] [Full Text] [Related]

  • 14. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.
    Fearon DT.
    Proc Natl Acad Sci U S A; 1978 Apr 01; 75(4):1971-5. PubMed ID: 273923
    [Abstract] [Full Text] [Related]

  • 15. Two types of C3 nephritic factor: properdin-dependent C3NeF and properdin-independent C3NeF.
    Tanuma Y, Ohi H, Hatano M.
    Clin Immunol Immunopathol; 1990 Aug 01; 56(2):226-38. PubMed ID: 2143128
    [Abstract] [Full Text] [Related]

  • 16. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
    Fishelson Z, Müller-Eberhard HJ.
    J Immunol; 1984 Mar 01; 132(3):1425-9. PubMed ID: 6229580
    [Abstract] [Full Text] [Related]

  • 17. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
    Ito S, Tamura N, Fujita T.
    Immunology; 1989 Dec 01; 68(4):449-52. PubMed ID: 2481642
    [Abstract] [Full Text] [Related]

  • 18. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
    Gigli I, Fujita T, Nussenzweig V.
    Proc Natl Acad Sci U S A; 1979 Dec 01; 76(12):6596-600. PubMed ID: 293746
    [Abstract] [Full Text] [Related]

  • 19. Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP).
    Seya T, Okada M, Matsumoto M, Hong KS, Kinoshita T, Atkinson JP.
    Mol Immunol; 1991 Oct 01; 28(10):1137-47. PubMed ID: 1833639
    [Abstract] [Full Text] [Related]

  • 20. Stabilization of homologous and heterologous cell-bound amplification convertases, C3bBb, by C3 nephritic factor.
    Daha MR, Van Es LA.
    Immunology; 1981 May 01; 43(1):33-8. PubMed ID: 6166544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.